{
    "id": "47095796",
    "text": "Sir Stephen Robert Bloom FRS (born 24 October 1942) is a British Professor of Medicine at Imperial College London where he leads the Diabetes, Endocrinology and Metabolism division. ==Education== Bloom was educated at Queens' College, Cambridge where he was awarded a Master of Arts degree in 1968 and a Doctor of Medicine degree in 1979. He received his Doctor of Science (DSc) degree from the University of London in 1982. Bloom completed appointments as a house officer, senior house officer and specialist registrar at Middlesex Hospital, University College London, where he also received his Medical Research Council (MRC) Clinical Research Fellowship training. ==Awards and honours== Bloom was elected a Fellow of the Royal Society (FRS) in 2013. His nomination reads: Blooms research has been funded by grants awarded by the BBSRC and Medical Research Council (MRC). Bloom was also knighted in the Queen's 2012 New Year Honours, and awarded Fellowships of the Royal College of Physicians (FRCP), Royal College of Pathologists (FRCPath), the Academy of Medical Sciences (FMedSci) and the Royal Society of Biology (FRSB). Bloom is Chairman of a Biotechnology Company, Zihipp, which completed round A funding in January 2020. It specialises in peptide hormone analogues to treat obesity and diabetes. ==References== Category:Living people Category:Fellows of the Royal Society Category:1942 births Category:Knights Bachelor Category:Fellows of the Royal Society of Biology Category:Alumni of Queens' College, Cambridge ",
    "title": "Stephen R. Bloom"
}